2021年最新SCI期刊影响因子查询系统
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS 期刊详细信息
基本信息
期刊名称 | JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS |
---|---|
期刊ISSN | 0731-7085 |
期刊官方网站 | http://www.elsevier.com/wps/find/journaldescription.cws_home/525434/description#description |
是否OA | 否 |
出版商 | Elsevier |
出版周期 | Semimonthly |
始发年份 | 1983 |
年文章数 | 726 |
最新影响因子 | 3.571(2021) |
中科院SCI期刊分区
大类学科 | 小类学科 | Top | 综述 |
---|---|---|---|
医学3区 | CHEMISTRY, ANALYTICAL 分析化学2区 | 否 | 否 |
PHARMACOLOGY & PHARMACY 药学3区 |
CiteScore
CiteScore排名 | CiteScore | SJR | SNIP | ||
---|---|---|---|---|---|
学科 | 排名 | 百分位 | 3.15 | 0.786 | 1.144 |
Chemistry Spectroscopy |
15 / 69 | 78% |
|||
Biochemistry, Genetics and Molecular Biology Clinical Biochemistry |
28 / 115 | 76% |
|||
Chemistry Analytical Chemistry |
28 / 110 | 75% |
|||
Pharmacology, Toxicology and Pharmaceutics Pharmaceutical Science |
32 / 164 | 80% |
|||
Pharmacology, Toxicology and Pharmaceutics Drug Discovery |
38 / 146 | 74% |
补充信息
自引率 | 13.00% |
---|---|
H-index | 114 |
SCI收录状况 |
Science Citation Index
Science Citation Index Expanded |
官方审稿时间 | |
网友分享审稿时间 | 数据统计中,敬请期待。 |
PubMed Central (PML) | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0731-7085%5BISSN%5D |
投稿指南
期刊投稿网址 | http://ees.elsevier.com/jpba/ |
---|---|
收稿范围 | This journal is an international medium directed towards the needs of academic, clinical, government and industrial analysis by publishing original research reports and critical reviews on pharmaceutical and biomedical analysis. It covers the interdisciplinary aspects of analysis in the pharmaceutical, biomedical and clinical sciences, including developments in analytical methodology, instrumentation, computation and interpretation. Submissions on novel applications focussing on drug purity and stability studies, pharmacokinetics, therapeutic monitoring, metabolic profiling; drug-related aspects of analytical biochemistry and forensic toxicology; quality assurance in the pharmaceutical industry are also welcome. Studies from areas of well established and poorly selective methods, such as UV-VIS spectrophotometry (including derivative and multi-wavelength measurements), basic electroanalytical (potentiometric, polarographic and voltammetric) methods, fluorimetry, flow-injection analysis, etc. are accepted for publication in exceptional cases only, if a unique and substantial advantage over presently known systems is demonstrated. The same applies to the assay of simple drug formulations by any kind of methods and the determination of drugs in biological samples based merely on spiked samples. Drug purity/stability studies should contain information on the structure elucidation of the impurities/degradants. Papers dealing with the analytical aspects of traditional folk medicines are acceptable if the results are expected to attract the interest of readers also outside the area of origin. Bioanalytical papers (pharmacokinetic, bioequivalence, protein and DNA binding studies) are accepted if the focus is on innovative analytical methodology. In determining the suitability of submitted articles for publication, particular scrutiny will be placed on the degree of novelty and significance of the research and the extent to which it adds to existing knowledge in pharmaceutical and biomedical analysis. In all submissions to the journal, authors must address the question of how their proposed methodology compares with previously reported methods. A substantial body of work cannot be fractionated into different shorter papers. |
收录体裁 | Reviews Full Length Research Papers Short Communications |
投稿指南 | https://www.elsevier.com/journals/journal-of-pharmaceutical-and-biomedical-analysis/0731-7085/guide-for-authors |
投稿模板 | |
参考文献格式 | https://www.elsevier.com/journals/journal-of-pharmaceutical-and-biomedical-analysis/0731-7085/guide-for-authors |
编辑信息 |